MK-0646
Term · Oncology and biomedicine · MLC-T-ONC-005431
A substance being studied in the treatment of many types of cancer. MK-0646 binds to a protein called insulin-like growth factor receptor (IGFR) on the surface of cells. This may prevent the cells from growing when IGF is present. It may also kill cancer cells. MK-0646 is a type of monoclonal antibody. Also called anti-IGF1R recombinant monoclonal antibody MK-0646.
| Identifier | MLC-T-ONC-005431 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | anti-IGF1R recombinant monoclonal antibody MK-0646 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005431",
"term": "MK-0646",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of many types of cancer. MK-0646 binds to a protein called insulin-like growth factor receptor (IGFR) on the surface of cells. This may prevent the cells from growing when IGF is present. It may also kill cancer cells. MK-0646 is a type of monoclonal antibody. Also called anti-IGF1R recombinant monoclonal antibody MK-0646.",
"expansions": [
"anti-IGF1R recombinant monoclonal antibody MK-0646"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/mk-0646/"
}
Record 11,133 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.